Denali Therapeutics Inc (DNLI)
R&D Expense Growth
-6.57%
Quarterly · Period ending:
DNLI R&D Expense Growth
Latest reported-6.57%period ending
Latest reported-6.57%period ending
DNLI Quarterly R&D Growth (QoQ) (0.00% → -6.57%)
Latest values, visible window
High-resolution chart · PNG
DNLI r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -6.5742% | |
| 6.0681% | |
| -3.9676% | |
| -0.7264% | |
| -11.6419% | |
| 16.4751% | |
| 1.5768% | |
| 7.4826% | |
| -14.5931% | |
| -0.73% | |
| 20.1322% | |
| -7.9809% | |
| -24.2951% | |
| 39.8487% | |
| 4.9268% | |
| -5.3388% | |
| 7.711% | |
| 26.846% | |
| -5.1468% | |
| 8.8996% | |
| 9.1418% | |
| 9.9812% | |
| 1.9347% | |
| 1.0385% | |
| 4.1869% | |
| -1.0378% | |
| -1.8898% | |
| 1.2721% | |
| 38.7161% | |
| -6.2793% | |
| 31.6216% | |
| -41.8403% | |
| 150.4155% | |
| 12.7118% | |
| -0.2376% | |
| -2.5731% | |
| 2.8912% | |
| 10.4005% | |
| -39.8612% | |
| 78.596% | |
| 0% | |
| 0% |